Delivery of siRNA to the mouse lung via a functionalized lipopolyamine. - Wikidata - wikimedia - TriplyDB

Delivery of siRNA to the mouse lung via a functionalized lipopolyamine.

Delivery of siRNA to the mouse lung via a functionalized lipopolyamine.

http://www.wikidata.org/entity/Q35665154

about

siRNA delivery to the lung: what's new?Progress toward in vivo use of siRNAs-II In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight Systems approaches to design of targeted therapeutic delivery.Turning Squalene into Cationic Lipid Allows a Delivery of siRNA in Cultured Cells Differential bioreactivity of neutral, cationic and anionic polystyrene nanoparticles with cells from the human alveolar compartment: robust response of alveolar type 1 epithelial cells Genetic and hypoxic alterations of the microRNA-210-ISCU1/2 axis promote iron-sulfur deficiency and pulmonary hypertension.Lipid nanoparticle delivery of a microRNA-145 inhibitor improves experimental pulmonary hypertension Enhanced intrapulmonary delivery of anticancer siRNA for lung cancer therapy using cationic ethylphosphocholine-based nanolipoplexes.Development of a Positive-readout Mouse Model of siRNA Pharmacodynamics.Nanomedicine: de novo design of nanodrugs.Epigenetic targets for novel therapies of lung diseases.Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines Delivery of therapeutic siRNA to the lung endothelium via novel Lipoplex formulation DACC.A High-Throughput Method for Direct Detection of Therapeutic Oligonucleotide-Induced Gene Silencing In Vivo.Intracellular cleavable poly(2-dimethylaminoethyl methacrylate) functionalized mesoporous silica nanoparticles for efficient siRNA delivery in vitro and in vivo.

P2860

Q27022043-E87F45F5-AD6B-451E-A7A2-EA0EEA5C5981 Q28255877-295B8ECF-5C57-47AA-97F0-AD19B5544DEE Q34393539-F1447E74-9D60-488F-A8C3-A01D2DCD3517 Q35623160-7BA1DF1D-765D-4484-892B-3DB7590942EF Q35635285-93A1575D-1FD0-43F1-B776-E3CF2402DB6D Q35680554-FA8EE260-12E9-4ADB-8690-C31559F92738 Q35695350-C7FE6868-25A4-4C26-9813-27F716E7869D Q35770214-D8E251FD-DA2C-4A8B-AEFD-A4D8277E43CE Q36740249-B36ADE62-33FE-4BE8-AC0F-8215F40BA8AB Q37467849-5AA1C5EA-7D1A-4D19-9588-10370D196425 Q38168683-246AE241-6D63-4E6B-8116-4C0CD56465C8 Q38275276-02C8C72B-522B-4EC7-A77C-B12B2B313111 Q38674444-92AA896F-4B5F-4A78-8CE8-24A4AA050F2E Q38692510-C2E370E5-DB71-482A-92EB-C4338B248AA9 Q40272499-B384ADB4-893B-4F37-BDE8-39356291747F Q46261083-31D96073-C81E-43C9-8550-CA077452751F

P2860

Delivery of siRNA to the mouse lung via a functionalized lipopolyamine.

http://www.wikidata.org/entity/Q35665154

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Delivery of siRNA to the mouse lung via a functionalized lipopolyamine.

@ast

Delivery of siRNA to the mouse lung via a functionalized lipopolyamine.

@en

type

label

Delivery of siRNA to the mouse lung via a functionalized lipopolyamine.

@ast

Delivery of siRNA to the mouse lung via a functionalized lipopolyamine.

@en

prefLabel

Delivery of siRNA to the mouse lung via a functionalized lipopolyamine.

@ast

Delivery of siRNA to the mouse lung via a functionalized lipopolyamine.

@en

P1433

Q35665154-12130EF4-A984-42FD-A69E-8806B1806726

P1476

Q35665154-8D6E82D8-6057-4661-979C-837163DA3470

P2093

Q35665154-0C12C720-5529-4A13-976F-585F98148EB4

Q35665154-22081D79-4090-4979-8A75-5EDC078F6206

Q35665154-31D9768B-C410-4257-9CE2-7AF45A6A6C08

Q35665154-3E32BC55-9E06-4F32-818E-BF9C8C809791

Q35665154-50B516D3-38C1-450E-A103-A14CCC7D5D52

Q35665154-5BD62DCC-D1CE-4535-81A5-609C86296BEA

Q35665154-5E5068D3-A296-400E-9026-43024A2BF27A

Q35665154-64016920-AC92-4377-98E0-3BA80E854C65

Q35665154-98056382-9A0E-41D6-B481-91C50DF0B01B

Q35665154-ADDA3521-CEF2-43B8-80BC-213990BE8480

P2860

Q35665154-03360F45-1CD2-40C7-8ADF-5F97875DEF74

Q35665154-0FA476EF-D56B-4141-AE56-CCAEB2C48F0E

Q35665154-138AEE89-7B21-4083-9116-1CB2624EC209

Q35665154-1591D380-7544-44CC-87FC-99694D5465C8

Q35665154-15F56AA2-FA66-454B-8430-22C43A079BB6

Q35665154-2983C851-8172-448A-8544-57C2334CE8F5

Q35665154-2D687EFD-EFDA-47E4-A987-C10A750C63D2

Q35665154-30E89A0C-3283-47DA-AE41-557D97573809

Q35665154-37CE85F4-4479-411D-8B92-A433429335D8

Q35665154-40EE18D6-22B3-48F4-8732-264AF981BB69

P304

Q35665154-F49DAF88-6DB3-4672-83B4-304614FD8C23

P31

Q35665154-E8E531D2-5EBB-4B8D-8977-6C4F8FCEE306

P356

Q35665154-15709A3B-F77C-45CC-84DD-2D2CF33F304B

P433

Q35665154-F9558780-B409-472E-BFFE-1FFF7D2F5B0E

P478

Q35665154-36A35704-F4CA-4329-83CE-261D422B97D9

P50

Q35665154-670CD56F-C707-476C-B3ED-8EBC56344EEC

P577

Q35665154-8993A8E2-2998-4B36-B044-3E00D7F08CB9

P5875

Q35665154-7108262B-80CB-4CBF-A347-BF9A8D01CAE1

P698

Q35665154-C1E12B3B-2BEF-42E2-8280-865C67AF016D

P932

Q35665154-0AB54A8F-69C5-4B5A-99FF-983E4488DB17

P356

P1433

Molecular Therapy

P1476

Delivery of siRNA to the mouse lung via a functionalized lipopolyamine.

@en

P2093

Andrea Schuster

http://www.w3.org/2001/XMLSchema#string

Angela Rea-Ramsey

http://www.w3.org/2001/XMLSchema#string

Anke Geick

http://www.w3.org/2001/XMLSchema#string

Diane McClure

http://www.w3.org/2001/XMLSchema#string

Elaine Brunhoeber

http://www.w3.org/2001/XMLSchema#string

Gregory Slobodkin

http://www.w3.org/2001/XMLSchema#string

Jason G Fewell

http://www.w3.org/2001/XMLSchema#string

Jeff Sparks

http://www.w3.org/2001/XMLSchema#string

Jennifer Rice

http://www.w3.org/2001/XMLSchema#string

Kerstin Jahn-Hofmann

http://www.w3.org/2001/XMLSchema#string

P2860

Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential

Progress towards in vivo use of siRNAs

Abasic oligodeoxyribonucleoside phosphorothioates: synthesis and evaluation as anti-HIV-1 agents

Effects of apolipoproteins A-IV and A-I on the uptake of phospholipid liposomes by hepatocytes

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus

A combinatorial library of lipid-like materials for delivery of RNAi therapeutics.

Lipid-like materials for low-dose, in vivo gene silencing

Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance.

A status report on RNAi therapeutics.

P304

91-100

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2011.210

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Hans-Peter Vornlocher

P577

2011-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51708616

http://www.w3.org/2001/XMLSchema#string

P698

21988874

http://www.w3.org/2001/XMLSchema#string

P932

3255578

http://www.w3.org/2001/XMLSchema#string